Appointment of liquidators (MVL)
Phosphate Therapeutics LTD. enters members' voluntary liquidation
In short: Phosphate Therapeutics LTD. (company no. 07618820) entered members' voluntary liquidation, a solvent and planned closure, according to a Appointment of liquidators (MVL) notice published in The London Gazette on 06 August 2026. The office holders are Trevor Oates (IP number 26290) of Ernst & Young LLP, 12 Wellington Place, Leeds, LS1 4AP; Derek Neil Hyslop (IP number 9970) of Ernst & Young LLP, Atria One, 14, appointed 31 July 2026. The company's business: 72110 - research and experimental development on biotechnology.
The notice announces the appointment of joint liquidators for PHOSPHATE THERAPEUTICS LTD in a members' voluntary liquidation.
Notice details
- Company
- PHOSPHATE THERAPEUTICS LTD
- Company number
- 07618820
- Nature of business
- 72110 - Research and experimental development on biotechnology
- Registered office
- 12 Wellington Place, Leeds, LS1 4AP
- Type of liquidation
- Members Voluntary Liquidation
- Liquidator(s)
- Trevor Oates (IP number 26290) of Ernst & Young LLP, 12 Wellington Place, Leeds, LS1 4AP; Derek Neil Hyslop (IP number 9970) of Ernst & Young LLP, Atria One, 144 Morrison Street, Edinburgh, EH3 8EX
- Date of appointment
- 31 July 2026
- Appointed by
- Members
- Contact
- Mark Chapman on +44 113 298 2602
What this notice means
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Read more: What is Liquidation?.
All notices for Phosphate Therapeutics LTD.
3 Gazette notices on record for company no. 07618820, newest first. The full history, with last filed accounts, is on the Phosphate Therapeutics LTD. company record.
- Notices to creditors (MVL) 06 Aug 2026
- Resolution for winding up (MVL) 06 Aug 2026
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If PHOSPHATE THERAPEUTICS LTD. owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2's founder has turned around UK businesses since 1990, and K2 has backed and restructured them since 2001, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at PHOSPHATE THERAPEUTICS LTD. or something similar, start the conversation early.
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2's founder has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Frequently asked questions
Is Phosphate Therapeutics LTD. in financial difficulty?
No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Appointment of liquidators (MVL) for Phosphate Therapeutics LTD. (company no. 07618820) on 06 August 2026.
What does a Appointment of liquidators (MVL) mean?
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Who is dealing with the liquidation?
The office holders named in the notice: Trevor Oates (IP number 26290) of Ernst & Young LLP, 12 Wellington Place, Leeds, LS1 4AP; Derek Neil Hyslop (IP number 9970) of Ernst & Young LLP, Atria One, 14, appointed 31 July 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.